Trending

[PDF] Sarcopenia Treatment Market size and Generated Opportunities of volume and value

This image has an empty alt attribute; its file name is medical-3.jpg

Sarcopenia, a condition commonly referred to as Sarcoptic Squamous Cell Disease (SCMD), is an aging-related disorder characterized by the rapid loss of sarcoplasmic muscle tissue, resulting in abnormal muscle weakness and decreased muscular performance. Sarcopenia primarily affects older men and women (although cases are also reported among children). The diagnosis of Sarcopenia can be based on physical symptoms such as muscle weakness, decreased muscle performance, joint pain, decreased physical functioning, weight gain, increased body fat, decreased libido, and increased aging. Other signs and symptoms include bone pain, fractures, and an increased risk of infection. Sarcopenia can cause significant disabilities and often leads to death if not treated.

FREE | Request Sample is Available @ https://www.coherentmarketinsights.com/insight/request-sample/2770

*The Sample only consist of Table of Content (ToC).
Research Framework of the actual report.
Research Methodology adopted for it.

Major Company Profiles Covered in This Report: GlaxoSmithKline, Radius Health Inc., Five Prime Therapeutics, Inc., Abbott Laboratories, Pfizer Inc., Nestle S.A., Sanofi S.A., Bayer AG, and Novartis AG, Cadila Healthcare Ltd.

The growing aging population is a key factor driving growth of the Sarcopenia treatment market. According to the United Nation, there were 703 million persons aged 65 years or over in the world in 2019. The number of older persons is projected to double to 1.5 billion in 2050. Moreover, rising awareness regarding Sarcopenia treatment is again fostering the growth of the market.

Increasing investment by key players in the research & development activities of this treatment is expected to augment growth of the market. For instance, in March 2018, Biophytis demonstrated results of Sarconeos (BIO101) for treating sarcopenia, and announced patient enrollment for the SARA-INT international clinical study, at the 8th International Conference on Frailty & Sarcopenia Research (ICFSR).

Covid-19 Impact Analysis

The Covid-19 pandemic has handicapped the entire world due to various restrictions on logistics and production but an upsurge in the healthcare sector, especially in pharma industry. The increasing number of lifestyle diseases due to lack of physical activities during lockdown has led to sarcopenia especially among the aging population. This has created high demand for sarcopenia treatment drugs during the COVID-19 pandemic.

Request Free research report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2770

Key Takeaways:

The Sarcopenia treatment is expected to exhibit a CAGR of XX % over the forecast period, owing to the continuous launch of a novel drug to cater to growing demand. Also, growing various lifestyle associated disease is again propelling growth of the market.

North America is expected to witness strong growth in the market in the near future owing to growing research & development activities. For instance, in February 2021, MYOS CORP, a research-based advanced Nutrition Company with divisions that address both Human Nutrition and Animal Health, announced that it has been granted United States Patent #10,925,904 by the United States Patent and Trademark Office (USPTO)

Inquire more about this report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/2770

Some Notable Offerings by Coherent Market Insights Report on Sarcopenia Treatment market:

• We will provide you an analysis of the extent to which this Sarcopenia Treatment market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better.

• We will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others.

• Also, this report will help you to identify any trends to forecast growth rates.

• The analyzed report will forecast the general tendency for supply and demand.

How Coherent Market Insights Assists in Making Strategic Moves For Sarcopenia Treatment Market Manufacturer?

• The data provided in the Sarcopenia Treatment market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.

• The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

Also, Research Report Examines:

Competitive companies and manufacturers in global market

By Product Type, Applications & Growth Factors

Industry Status and Outlook for Major Applications / End Users / Usage Area

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

nirav

About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformation growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

Related Articles

Back to top button